HomeBLAB • CNSX
add
Britannia Life Sciences Inc
Previous close
$0.095
Year range
$0.030 - $0.14
Market cap
14.64M CAD
Avg Volume
92.31K
P/E ratio
2.08
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 169.77K | 9.00% |
Operating expense | 390.64K | -9.67% |
Net income | -690.95K | 6.40% |
Net profit margin | -406.99 | 14.13% |
Earnings per share | — | — |
EBITDA | -346.77K | -8.76% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.14M | 726.72% |
Total assets | 9.81M | -54.85% |
Total liabilities | 4.26M | -72.50% |
Total equity | 5.55M | — |
Shares outstanding | 162.25M | — |
Price to book | 3.17 | — |
Return on assets | -8.46% | — |
Return on capital | -11.67% | — |
Cash Flow
Net change in cash
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -690.95K | 6.40% |
Cash from operations | -1.15M | -8,923.55% |
Cash from investing | -250.04K | -190.05% |
Cash from financing | -29.85K | 94.26% |
Net change in cash | -1.44M | -147.47% |
Free cash flow | -1.17M | -379.24% |
About
Founded
2000
Headquarters
Website
Employees
28
